Clinical Trial: Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07451158) titled 'Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment' on Nov. 17, 2025.

Brief Summary: Multicenter, double-blind, and randomized controlled trial of Ultra-Distal Transcutaneous Electrical Nerve Stimulation (TENS) Device for Migraine treatment.

Study Start Date: Nov. 15, 2025

Study Type: INTERVENTIONAL

Condition: Migraine

Intervention: DEVICE: Trail of Ultral-distal Transcutaneous Electrical Nerve Stimulation

When subjects report experiencing or impending headache episodes, complete the VAS assessment and immediately administer transcutaneous electrical stimulation (TENS...